Neuropathic Pain in Survivors of Breast Cancer

Completed

Conditions studied: Breast Cancer

In brief

The objectives of this study are to: 1) describe the prevalence of neuropathic pain (NP) in breast cancer survivors and 2) to develop preliminary statistical risk models for predicting the risk for NP incorporating disease-related variables (e.g., stage of disease, location of tumor), treatment variables (chemotherapy, dose, duration; and other cancer therapy), clinical health status (e.g., comorbid conditions), and sociodemographic characteristics (e.g., age, sex, race). Researchers will also gather data to answer the following secondary aims: 1. To assess the impact of NP on quality of life. 2. To assess the current management of NP in cancer (current medication, duration of such treatment, reasons for discontinuation) and the outcomes of this management.

Key facts

Study ID

NCT00535067

Run by

M.D. Anderson Cancer Center

People needed

239

Starts

2007-09-01

Expected to finish

2013-11-01

Last updated by the study team

2015-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Breast cancer patients who were participants in clinical trials (ID98-240; ID94-002) for taxanes during 1994-2001
• Alive and with current contact information
• Age ≥ 18 years. (This restriction is based on inclusion criteria for the clinical trials from which subjects will be recruited. All patients will be at least 18 years or older for this study.)

You may not qualify if…

• None

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.